Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Next Generation Sequencing (NGS) Informatics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Products & Services
5.3.2. By Application
5.3.3. By End User
5.3.4. By Region
6. North America Next Generation Sequencing (NGS) Informatics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Products & Services
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Products & Services
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Products & Services
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Products & Services
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Products & Services
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Products & Services
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.1.2.4. By Country
7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Products & Services
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Products & Services
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Products & Services
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Products & Services
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Products & Services
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Products & Services
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Products & Services
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Products & Services
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Products & Services
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Products & Services
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. South America Next Generation Sequencing (NGS) Informatics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Products & Services
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Products & Services
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Products & Services
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Products & Services
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Products & Services
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Products & Services
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Products & Services
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Products & Services
10.3.3.2.2. By Application
10.3.3.2.3. By End User
10.3.4. Turkey Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Products & Services
10.3.4.2.2. By Application
10.3.5. Egypt Next Generation Sequencing (NGS) Informatics Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Products & Services
10.3.5.2.2. By Application
10.3.5.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.1.1. Rise in Prevalence of Chronic Diseases
11.1.2. Increase in clinical research for Next Generation Sequencing (NGS)
11.1.3. Substitution of DNA Microarray Technology
12. Challenges
12.1.1. Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments
12.1.2. Poor reimbursement rates for Next Generation Sequencing (NGS) across the globe
13. Market Trends & Developments
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.5.1. Abbott Laboratories, Inc.
14.5.2. F. Hoffmann-La Roche Ltd.
14.5.3. PerkinElmer, Inc.
14.5.4. SOPHiA GENETICS SA
14.5.5. Precigen, Inc.
14.5.6. QIAGEN N.V.
14.5.7. Illumina, Inc.
14.5.8. Agilent Technologies, Inc.
14.5.9. Eagle Genomics Limited
14.5.10. BGI Genomics Co., Ltd.
15. Strategic Recommendations